• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝素-Mn²⁺ 法测定高密度脂蛋白胆固醇:脂血样本的超滤方法

Heparin--Mn2+ quantitation of high-density-lipoprotein cholesterol: an ultrafiltration procedure for lipemic samples.

作者信息

Warnick G R, Albers J J

出版信息

Clin Chem. 1978 Jun;24(6):900-4.

PMID:207462
Abstract

We describe a modified heparin--Mn2+ procedure for high-density-lipoprotein cholesterol quantitation, especially in lipemic samples. High-density-lipoproteins may be estimated as cholesterol remaining in plasma supernates after precipitation of other lipoproteins by heparin and Mn2+ treatment. However, in lipemic samples or those from non-fasting individuals, the lower density of the precipitated chylomicrons, very-low-, and low-density-lipoproteins frequently prevents their sedimentation by the usual low-speed centrifugation, and high-density-lipoprotein cholesterol thus is overestimated in the resulting turbid supernates. Sedimentation is improved by a twofold increase in Mn2+ concentration to 92 mmol/liter. The procedure reported here produced clear supernates in more than 95% of samples tested. Any remaining turbid supernates can be cleared by a simple, convenient ultrafiltration technique. The filtration removed essentially all of the very-low- and low-density-lipoproteins without removing appreciable amounts of high-density-lipoproteins.

摘要

我们描述了一种改良的肝素-Mn2+法用于高密度脂蛋白胆固醇定量,特别是在脂血样本中。高密度脂蛋白可通过肝素和Mn2+处理沉淀其他脂蛋白后,以血浆上清液中剩余的胆固醇来估算。然而,在脂血样本或非空腹个体的样本中,沉淀的乳糜微粒、极低密度和低密度脂蛋白密度较低,常常无法通过常规低速离心沉降,因此在产生的浑浊上清液中高密度脂蛋白胆固醇被高估。将Mn2+浓度提高两倍至92 mmol/升可改善沉降。此处报道的方法在超过95%的测试样本中产生了清澈的上清液。任何剩余的浑浊上清液都可以通过一种简单便捷的超滤技术清除。过滤基本去除了所有极低密度和低密度脂蛋白,而没有去除大量的高密度脂蛋白。

相似文献

1
Heparin--Mn2+ quantitation of high-density-lipoprotein cholesterol: an ultrafiltration procedure for lipemic samples.肝素-Mn²⁺ 法测定高密度脂蛋白胆固醇:脂血样本的超滤方法
Clin Chem. 1978 Jun;24(6):900-4.
2
A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.用于估算高密度脂蛋白胆固醇的肝素-锰沉淀法的综合评估。
J Lipid Res. 1978 Jan;19(1):65-76.
3
Multilaboratory evaluation of an ultrafiltration procedure for high density lipoprotein cholesterol quantification in turbid heparin-manganese supernates.用于测定混浊肝素-锰上清液中高密度脂蛋白胆固醇的超滤程序的多实验室评估。
J Lipid Res. 1981 Aug;22(6):1015-20.
4
Presence of unsedimented precipitate in visually non-turbid supernates in the heparin-manganese method for HDL-cholesterol quantitation.在肝素-锰法测定高密度脂蛋白胆固醇时,在视觉上无浑浊的上清液中存在未沉淀的沉淀物。
Clin Biochem. 1986 Aug;19(4):209-11. doi: 10.1016/s0009-9120(86)80027-3.
5
Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein.三种用于估算高密度脂蛋白中胆固醇的肝素-Mn2+沉淀法的多实验室比较
Clin Chem. 1978 Jun;24(6):853-6.
6
Evaluation of commercial heparin preparations for use in the heparin-Mn2+ method for measuring cholesterol in high-sensity lipoprotein.用于肝素-Mn2+法测定高密度脂蛋白胆固醇的市售肝素制剂的评估
Clin Chem. 1979 Jul;25(7):1309-13.
7
High-density-lipoprotein cholesterol in heparin-MnCl2 supernates determined with the Dow enzymic method after precipitation of Mn2+ with HCO3-.用Dow酶法在通过HCO₃⁻沉淀Mn²⁺后测定肝素-MnCl₂上清液中的高密度脂蛋白胆固醇。
Clin Chem. 1984 Jun;30(6):839-42.
8
Plasma high-density lipoprotein cholesterol concentrations determined after removal of other lipoproteins by heparin/manganese precipitation or by ultracentrifugation.通过肝素/锰沉淀法或超速离心法去除其他脂蛋白后测定的血浆高密度脂蛋白胆固醇浓度。
Clin Chem. 1976 Nov;22(11):1828-34.
9
Dual-precipitation method for lipoprotein quantitation: improvement by membrane ultrafiltration of lipemic samples.脂蛋白定量的双沉淀法:通过对脂血样本进行膜超滤改进
Clin Chem. 1974 Mar;20(3):394-5.
10
Use of the Du Pont aca to measure cholesterol in high-density lipoprotein fractions prepared by the heparin/Mn2+ precipitation method.使用杜邦aca法测定通过肝素/Mn2+沉淀法制备的高密度脂蛋白组分中的胆固醇。
Clin Chem. 1978 Jan;24(1):161-5.

引用本文的文献

1
Sex-Specific Blood Pressure Trajectories and Cardiovascular Disease in Type 1 Diabetes: 32-Year Follow-up of the Pittsburgh Epidemiology of Diabetes Complications Cohort.1型糖尿病患者特定性别的血压轨迹与心血管疾病:匹兹堡糖尿病并发症流行病学队列32年随访研究
Diabetes Care. 2025 Apr 1;48(4):605-613. doi: 10.2337/dc24-2258.
2
High-Density Lipoprotein Particle Concentration and Size Predict Incident Coronary Artery Disease Events in a Cohort With Type 1 Diabetes.高密度脂蛋白颗粒浓度和大小可预测 1 型糖尿病患者发生冠心病事件的风险。
J Am Heart Assoc. 2024 Jul 16;13(14):e034763. doi: 10.1161/JAHA.123.034763. Epub 2024 Jul 3.
3
An Epigenome-Wide Association Study of DNA Methylation and Proliferative Retinopathy over 28 Years in Type 1 Diabetes.
一项关于1型糖尿病患者28年间DNA甲基化与增殖性视网膜病变的全表观基因组关联研究。
Ophthalmol Sci. 2024 Feb 28;4(4):100497. doi: 10.1016/j.xops.2024.100497. eCollection 2024 Jul-Aug.
4
Sex differences in the associations of HDL particle concentration and cholesterol efflux capacity with incident coronary artery disease in type 1 diabetes: The RETRO HDLc cohort study.1 型糖尿病患者中高密度脂蛋白颗粒浓度和胆固醇流出能力与新发冠状动脉疾病的相关性的性别差异:RETO HDLc 队列研究。
J Clin Lipidol. 2024 Mar-Apr;18(2):e218-e229. doi: 10.1016/j.jacl.2024.01.004. Epub 2024 Jan 29.
5
HDL Particle Concentration and Size Predict Incident Coronary Artery Disease Events in People with Type 1 Diabetes.高密度脂蛋白颗粒浓度和大小可预测1型糖尿病患者发生冠状动脉疾病事件的风险。
medRxiv. 2023 Nov 7:2023.11.06.23298165. doi: 10.1101/2023.11.06.23298165.
6
Joint 30-year HbA1c and lipid trajectories and mortality in type 1 diabetes.1型糖尿病患者30年糖化血红蛋白和血脂变化轨迹与死亡率
Diabetes Res Clin Pract. 2022 Mar;185:109787. doi: 10.1016/j.diabres.2022.109787. Epub 2022 Feb 18.
7
30-Year Cardiovascular Disease in Type 1 Diabetes: Risk and Risk Factors Differ by Long-term Patterns of Glycemic Control.30 年心血管疾病在 1 型糖尿病患者中:风险和风险因素因长期血糖控制模式而异。
Diabetes Care. 2022 Jan 1;45(1):142-150. doi: 10.2337/dc21-1381.
8
Predictors of Change in Skin Intrinsic Fluorescence in Type 1 Diabetes: The Epidemiology of Diabetes Complications Study.1 型糖尿病皮肤固有荧光变化的预测因素:糖尿病并发症流行病学研究。
J Diabetes Sci Technol. 2021 Nov;15(6):1368-1376. doi: 10.1177/19322968211014337. Epub 2021 May 15.
9
Skin intrinsic fluorescence scores are a predictor of all-cause mortality risk in type 1 diabetes: The Epidemiology of Diabetes Complications study.皮肤固有荧光评分是 1 型糖尿病全因死亡风险的预测指标:糖尿病并发症的流行病学研究。
J Diabetes Complications. 2021 Feb;35(2):107770. doi: 10.1016/j.jdiacomp.2020.107770. Epub 2020 Oct 23.
10
High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes.高敏型心肌肌钙蛋白 T 与 N 末端脑利钠肽原在 1 型糖尿病患者心血管结局中的相关性。
Diabetes Care. 2020 Sep;43(9):2199-2207. doi: 10.2337/dc20-0359. Epub 2020 Jul 2.